Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) EBT (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed EBT for 16 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 131.54% to $1.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.3 million, a 113.41% increase, with the full-year FY2024 number at -$16.3 million, down 1468.18% from a year prior.
  • EBT was $1.6 million for Q3 2025 at Xtant Medical Holdings, down from $3.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $6.9 million in Q3 2023 to a low of -$5.0 million in Q3 2024.
  • A 5-year average of -$1.3 million and a median of -$2.2 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 36400.0% in 2022, then skyrocketed 396.2% in 2023.
  • Xtant Medical Holdings' EBT stood at -$2.4 million in 2021, then increased by 7.91% to -$2.2 million in 2022, then plummeted by 70.21% to -$3.7 million in 2023, then increased by 15.62% to -$3.1 million in 2024, then surged by 149.78% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's EBT are $1.6 million (Q3 2025), $3.8 million (Q2 2025), and $33000.0 (Q1 2025).